GENEART AG

International public company
Josef-Engert-Strasse 11, Regensburg,  D-93053, Germany
()49 0941 9 42 76 11, 49 0941 9 42 76 11 fax, http://www.geneart.com

Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: GENEART provides integrated system solutions for DNA engineering and processing based on the gene synthesis technology platform to deliver improved drugs and biotech products

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

GENEART AG, News and Information

Other News To Note.
BIOWORLD Today; 6/22/2009; 569 words; Geneart AG, of Regensburg, Germany, said it was awarded a contract for the design...the UK HIV Vaccine Consortium. The genes, optimized and customized by Geneart, are to be used as the basis for clinical trials. Lytix Biopharma AS...

Geneart AG (G6AG.F) Weekly Earnings Information.
TFN/Nelson's Foreign Earnings Reports; 4/19/2009; 326 words; Apr 19, 2009 (Thomson Financial via COMTEX) -- Company: Geneart AG (G6AG.F) Country: Germany Actual EPS for FY End (12/2008): 0.45 Current FY High EPS Estimate: 0.68 Current FY Low...

Recent studies by A. Eichlerstahlberg and co-authors add new data to botany findings.(Report)
Science Letter; 3/31/2009; 945 words; ...Chlamydomonas reinhardtii. Planta, 2009;229(4):873-883). For additional information, contact M. Heitzer, Geneart AG, Josef Engert Str 11, D-93053 Regensburg, Germany. Publisher contact information for the journal Planta is: Springer...

GENEART receives European Patent for Screening Process for Antiviral Therapeutics.(Company overview)
Internet Wire; 2/5/2009; 1163 words; ...genes for pharmaceutical research GENEART AG, global leader in gene synthesis...Prof. Dr. Ralf Wagner, CEO of GENEART AG. For further inquiries, please contact: Bernd Merkl GENEART AG Josef-Engert-Str. 11 93053 Regensburg...

GENEART Receives European Patent for Selective Evolution of Proteins.(Company overview)
Internet Wire; 1/20/2009; 1343 words; ...the development of innovative drugs GENEART AG, global leader in gene synthesis...Prof. Dr. Ralf Wagner, CEO of GENEART AG. For further inquiries, please contact: Bernd Merkl GENEART AG Josef-Engert-Str. 11 93053 Regensburg...

Recent News Articles

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.